RVL Pharmaceuticals PLC O1P.BE
€0.00
Last Updated: Oct 24, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is RVL Pharmaceuticals PLC Stock Halal?
Shariah Compliance Analysis of O1P.BE Stock
Germany Health Care Nano Cap No. As of September 2026, RVL Pharmaceuticals PLC (O1P.BE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. RVL Pharmaceuticals PLC does not pass Musaffa's business and financial screening criteria.
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The company is headquartered in Bridgewater, New Jersey and currently employs 125 full-time employees. The company went IPO on 2018-10-12. The firm is focused on developing and commercializing products for an underserved patient population in ocular medicine and medical aesthetics. The company operates in one business segment which focuses on developing and commercializing pharmaceutical products. The firm is commercializing Upneeq for treating acquired blepharoptosis (low-lying eyelids) in adults and is developing Arbaclofen ER tablets for alleviating spasticity in multiple sclerosis patients. Their healthcare provider customers include optometrists, ophthalmologists, oculoplastic surgeons, facial plastic surgeons, dermatologists, and other qualified practitioners. The target patient population comprises adults with droopy or low-lying eyelids, primarily females. Its commercial operations are managed by wholly owned subsidiaries, RVL Pharmaceuticals, Inc., and RVL Pharmacy, LLC.
O1P.BE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, RVL Pharmaceuticals PLC is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
RVL Pharmaceuticals PLC (O1P.BE) Chart
Financial Metrics & Statements of RVL Pharmaceuticals PLC (O1P.BE)
FAQ's for RVL Pharmaceuticals PLC (O1P.BE)
- As of September 2026, RVL Pharmaceuticals PLC O1P.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes RVL Pharmaceuticals PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in RVL Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of RVL Pharmaceuticals PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of RVL Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of RVL Pharmaceuticals PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for RVL Pharmaceuticals PLC (O1P.BE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
